Seguir
Mark N Adams
Mark N Adams
Postdoctoral Fellow, Queensland University of Technology, Brisbane, Australia
Dirección de correo verificada de qut.edu.au
Título
Citado por
Citado por
Año
Structure, function and pathophysiology of protease activated receptors
MN Adams, R Ramachandran, MK Yau, JY Suen, DP Fairlie, ...
Pharmacology & therapeutics, 2011
4792011
Nucleophosmin: from structure and function to disease development
JK Box, N Paquet, MN Adams, D Boucher, E Bolderson, KJ O’Byrne, ...
BMC molecular biology 17, 1-12, 2016
3002016
Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising
C Jekimovs, E Bolderson, A Suraweera, M Adams, KJ O’Byrne, ...
Frontiers in oncology 4, 86, 2014
1442014
Proteolysis-induced n-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of …
Y He, A Wortmann, LJ Burke, JC Reid, MN Adams, I Abdul-Jabbar, ...
Journal of Biological Chemistry 285 (34), 26162-26173, 2010
862010
Expression of CDCA3 is a prognostic biomarker and potential therapeutic target in non–small cell lung cancer
MN Adams, JT Burgess, Y He, K Gately, C Snell, SD Zhang, JD Hooper, ...
Journal of Thoracic Oncology 12 (7), 1071-1084, 2017
792017
Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)
C O’Leary, H Gasper, KB Sahin, M Tang, A Kulasinghe, MN Adams, ...
Pharmaceuticals 13 (10), 273, 2020
662020
The Role of Palmitoylation in Signalling, Cellular Trafficking and Plasma Membrane Localization of Protease-Activated Receptor-2
MN Adams, ME Christensen, Y He, NJ Waterhouse, JD Hooper
PLoS One 6 (11), e28018, 2011
622011
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
BS Harrington, Y He, CM Davies, SJ Wallace, MN Adams, EA Beaven, ...
British journal of cancer 114 (4), 417-426, 2016
602016
Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance
Y He, AC Wu, BS Harrington, CM Davies, SJ Wallace, MN Adams, ...
Oncogene 35 (4), 468-478, 2016
602016
Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)
AJ Ramsay, JC Reid, MN Adams, H Samaratunga, Y Dong, JA Clements, ...
Biological chemistry 389 (6), 653-668, 2008
552008
Barrier-to-autointegration factor 1 (Banf1) regulates poly [ADP-ribose] polymerase 1 (PARP1) activity following oxidative DNA damage
E Bolderson, JT Burgess, J Li, NS Gandhi, D Boucher, LV Croft, S Beard, ...
Nature communications 10 (1), 5501, 2019
502019
hSSB1 (NABP2/OBFC2B) is required for the repair of 8-oxo-guanine by the hOGG1-mediated base excision repair pathway
N Paquet, MN Adams, V Leong, NW Ashton, C Touma, R Gamsjaeger, ...
Nucleic acids research 43 (18), 8817-8829, 2015
492015
hSSB1 (NABP2/OBFC2B) is regulated by oxidative stress
N Paquet, MN Adams, NW Ashton, C Touma, R Gamsjaeger, L Cubeddu, ...
Scientific reports 6 (1), 27446, 2016
402016
EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface
MN Adams, BS Harrington, Y He, CM Davies, SJ Wallace, NP Chetty, ...
Oncogene 34 (11), 1375-1383, 2015
392015
Human single-stranded DNA binding protein 1 (hSSB1, OBFC2B), a critical component of the DNA damage response
LV Croft, E Bolderson, MN Adams, S El-Kamand, R Kariawasam, ...
Seminars in cell & developmental biology 86, 121-128, 2019
372019
CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin
Y He, CM Davies, BS Harrington, L Hellmers, Y Sheng, A Broomfield, ...
Oncogene 39 (1), 219-233, 2020
342020
Transcriptomic profiling of cardiac tissues from SARS‐CoV‐2 patients identifies DNA damage
A Kulasinghe, N Liu, CW Tan, J Monkman, JE Sinclair, DD Bhuva, ...
Immunology 168 (3), 403-419, 2023
332023
Spatial profiling identifies prognostic features of response to adjuvant therapy in triple negative breast cancer (TNBC)
A Kulasinghe, J Monkman, ET Shah, N Matigian, MN Adams, K O’Byrne
Frontiers in Oncology 11, 798296, 2022
322022
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC
SL Ryan, S Beard, MP Barr, K Umezawa, S Heavey, P Godwin, SG Gray, ...
Lung Cancer 135, 217-227, 2019
322019
Evaluation of antibodies directed against human protease-activated receptor-2
MN Adams, CN Pagel, EJ Mackie, JD Hooper
Naunyn-Schmiedeberg's archives of pharmacology 385, 861-873, 2012
312012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20